This cohort study examines the association of a recall-based nirsevimab immunization strategy with the incidence of clinically diagnosed all-cause bronchiolitis during the 2024-2025 respiratory syncytial virus season in Italy.
Boracchini, R., Canova, B., Cesarini, M., De Marchi, I., Brigadoi, G., Barbieri, E., et al. (2026). Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention. JAMA NETWORK OPEN, 9(5) [10.1001/jamanetworkopen.2026.13571].
Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention
Boracchini R.
Primo
;Canova B.;Cesarini M.;Cantarutti A.Co-ultimo
2026
Abstract
This cohort study examines the association of a recall-based nirsevimab immunization strategy with the incidence of clinically diagnosed all-cause bronchiolitis during the 2024-2025 respiratory syncytial virus season in Italy.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Boracchini et al-2026-JAMA Network Open-VoR.pdf
accesso aperto
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
475.35 kB
Formato
Adobe PDF
|
475.35 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
